Morinamide

Chemical compound
  • J04AK04 (WHO)
Legal statusLegal status
Identifiers
  • N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide
CAS Number
  • 952-54-5
PubChem CID
  • 70374
ChemSpider
  • 63555
UNII
  • 8CFL28PA3W
KEGG
  • D07248 checkY
CompTox Dashboard (EPA)
  • DTXSID4046159 Edit this at Wikidata
ECHA InfoCard100.012.237 Edit this at WikidataChemical and physical dataFormulaC10H14N4O2Molar mass222.248 g·mol−13D model (JSmol)
  • Interactive image
  • C1COCCN1CNC(=O)C2=NC=CN=C2
InChI
  • InChI=1S/C10H14N4O2/c15-10(9-7-11-1-2-12-9)13-8-14-3-5-16-6-4-14/h1-2,7H,3-6,8H2,(H,13,15)
  • Key:GVTLAVKAVSKBKK-UHFFFAOYSA-N
  (verify)

Morinamide (or morphazinamide, or morinamid) is a drug used in the treatment of tuberculosis.[2] It behaves as a prodrug for Pyrazinamide.

References

  1. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. ^ Bonanni G, Ciccariello M, Mancini P, Pace V, Sagliaschi G (1993). "Concomitant ceco-appendicular and urinary tuberculosis. Description of two rare cases: physiopathological and diagnostic remarks". Riv Eur Sci Med Farmacol. 15 (3–4): 171–4. PMID 7761665.
  • v
  • t
  • e
Nucleic acid inhibitor
Rifamycins/
RNA polymerase inhibitor
Antifolates/DSI
ASA
Topoisomerase inhibitors/
quinolones
Protein synthesis inhibitor
Aminoglycosides
Oxazolidone
Polypeptide antibiotics
Cell envelope antibiotic
Peptidoglycan layer
Arabinogalactan layer
Mycolic acid layer
Other/unknownCombinations
Stub icon

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e